ArticleVideo journal of sports medicine
Arthroscopic (Arthro) Delivery of MACI (Autologous Cultured Chondrocytes on a Porcine Collagen Membrane) for Defects on MFC and Trochlea With concomitant TTO.
Article in Video journal of sports medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chondral pathology of the knee-specifically involving the femoral condyles and trochlea-is commonly observed during knee arthroscopies. This condition may necessitate supplementary interventions, such as a concomitant tibial tuberosity osteotomy (TTO). Approaching this patient population with a straightforward, less invasive arthroscopic technique may offer an advanced solution. Indications: Arthro matrix-induced autologous chondrocyte implantation (MACI; autologous cultured chondrocytes on a porcine collagen membrane) targets symptomatic chondral lesions in the knee that are consistent with magnetic resonance imaging findings, which range in size from 2 to 4 cm Technique Description: This technique for the arthroscopic delivery of MACI for defects located on the trochlea and femoral condyles has been developed as a progressive advancement in the evolution of autologous chondrocyte implantation technology. The described technique addresses these defect locations by utilizing the same arthroscopic approach for both cartilage defect locations and a separate incision for TTO. The instruments used include 3 varieties of curettes, an arthroscopic cutter to score the cartilage, and the V-shuttle membrane delivery device. Furthermore, attention is dedicated to the medial and lateral approaches, patellar elevation for trochlear access, meticulous defect preparation, hemostasis and fluid management, and implant delivery. Arthroscopic surgical procedures generally result in reduced postoperative pain, necessitating a decreased analgesic requirement, an earlier and enhanced joint mobility, less postoperative muscle inhibition, and expedited recovery. Moreover, an arthroscopic approach may reduce the length of the surgical incision for patients concerned about cosmetic outcomes. Results: In contrast to various other arthroscopic procedures related to knee ligaments or meniscal injuries, the implementation of arthroscopic delivery of MACI for defects on the trochlea and femoral condyles of the knee offers a persuasive and readily executable alternative for a proficient surgeon, even when performed in conjunction with TTO. Discussion/Conclusion: This arthroscopic technique for the delivery of the MACI implant can effectively treat multiple knee chondral lesions in different compartments when paired with TTO. Advantages of this approach include minimal surgical disruption, the ability to perform combined knee arthroscopic procedures, a more desirable cosmetic appearance, and improved early postoperative recovery. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.